Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by YE Potapova
Intermediate-Dose Busulfan and Cyclophosphamide as a Conditioning Regimen for Bone Marrow Transplantation in a Case of Fanconi Anemia in Myelodysplastic Transformation
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Bone Marrow Transplantation From Matched Siblings in Patients With Fanconi Anemia Utilizing Low-Dose Cyclophosphamide, Thoracoabdominal Radiation and Antithymocyte Globulin
Bone Marrow Transplantation
Transplantation
Hematology
Thiotepa/Cyclophosphamide/Tbi as a Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Successful Bone Marrow Transplantation in a Girl With Fanconi Anemia and Preterminal Renal Failure
Bone Marrow Transplantation
Transplantation
Hematology
Rectus Hematoma Secondary to Vomiting: A Complication of Conditioning Regimen for Bone Marrow Transplantation.
Internal Medicine
Internal Medicine
Medicine
Busulfan Fludarabine vs Busulfan Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis
Bone Marrow Transplantation
Transplantation
Hematology
Unrelated Bone Marrow Transplantation Using a Reduced Intensity-Conditioning Regimen in Leukocyte Adhesion Deficiency
Bone Marrow Transplantation
Transplantation
Hematology
Combined Umbilical Cord Blood and Bone Marrow Transplantation From a Sibling in a Patient With Fanconi Anemia
Central-European Journal of Immunology
Allergy
Immunology
Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
